New insulin pump study aims to simplify diabetes management for type 2 patients

NCT ID NCT07070830

Completed Disease control Sponsor: Insulet Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a simplified approach to starting automated insulin delivery works safely in adults with type 2 diabetes. 56 participants used the Omnipod M System with a continuous glucose monitor, starting with either a lower or higher insulin dose. The goal was to see how well the system controlled blood sugar and how safe it was.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omnipod M Automated Insulin Delivery System with Dexcom G6 continuous glucose monitor
What this could lead to: If successful, this could make it easier for people with type 2 diabetes to start using an automated insulin pump, potentially improving blood sugar control without complex setup.
What could go wrong: This was a small, early feasibility study (56 participants) with no control group. Results may not apply to all people with type 2 diabetes, and the device still requires careful monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

AccellaCare

Wilmington, North Carolina, 28401, United States
Disease & Glandular Disease Clinic

San Antonio, Texas, 78229, United States
Emory University

Atlanta, Georgia, 30303, United States
Joslin Diabetes Center

Boston, Massachusetts, 02215, United States
MassResearch LLC.

Waltham, Massachusetts, 02453, United States
University of Colorado

Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.